Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020

NEXT STORY
vTv Therapeutics Presents Two Late-Breaking Poster Sessions on Simplici-T1 Study at the American Diabetes Association’s Virtual Sessions Supporting the Potential of TTP399 as First-in-Class Oral Adjunctive Therapy for Type 1 Diabetes Patients
PREV STORY
Medtronic Presents U.S. Pivotal Trial Data for MiniMed™ 780G Advanced Hybrid Closed Loop System with Automated Correction Bolus Feature
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease

author_avatar
NASDAQ Market News

Novavax to Participate at Two Upcoming Investor Conferences

GAITHERSBURG, Md., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced ...

author_avatar
NASDAQ Market News

Press release: Terveystalo continues to grow its footprint in well-being services: Kuntoutumisasema OTE Oy to become part of Terveystalo

On 14 December, Terveystalo signed a contract on acquiring the operations of Kuntoutumisasema OTE ...

author_avatar
NASDAQ Market News